Recently we have added cancer treatment with peptide therapies to our services.

Peptides are very small proteins that can easily enter cancer cells and either disrupt their cell membranes, vastly increase the penetration of other cancer therapies into the cancer cells or in general increase the immune defense of the body.

Here is one example of such a peptide:

Thymosin α-1

It is a major component of Thymosin Fraction 5 and is responsible for restoring and modulating immune function, particularly cell mediated immune function. Recent studies showed that Thymosin Alpha-1 molecule increased major histocompatibility complex (MHC) class-1 and Toll-like receptor expression as well as cytokine production, suggesting its immunoregulatory role.

It is actually an FDA approved medication after it received orphan drug approval status. It is widely used and studied in multiple types of cancer and viral illnesses. Many physicians are using thymosin for chronic fatigue and Lyme disease as well as autoimmune functions.

TA 1 is thought to modulate the immune system by augmenting T-cell function. TA1 may affect thymocytes by stimulating their differentiation or by converting them to active T cells.

It is administered as sub cutaneous injections.

Another peptide is iRGD which has been shown in a study to increase the penetration of the chemotherapeutic agent doxorubicin over 40 times.

More information on benefits of peptides in specific conditions to follow soon.